228 related articles for article (PubMed ID: 1322429)
1. Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro.
Auernhammer CJ; Stalla GK; Lange M; Pfeiffer A; Müller OA
J Clin Endocrinol Metab; 1992 Aug; 75(2):552-7. PubMed ID: 1322429
[TBL] [Abstract][Full Text] [Related]
2. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
3. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
4. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
[TBL] [Abstract][Full Text] [Related]
5. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
[TBL] [Abstract][Full Text] [Related]
7. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
Isidori AM; Kaltsas GA; Korbonits M; Pyle M; Gueorguiev M; Meinhardt A; Metz C; Petrovsky N; Popovic V; Bucala R; Grossman AB
J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
[TBL] [Abstract][Full Text] [Related]
8. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
[TBL] [Abstract][Full Text] [Related]
9. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
[TBL] [Abstract][Full Text] [Related]
10. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
[TBL] [Abstract][Full Text] [Related]
11. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
12. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
14. CRH in Cushing's syndrome.
Müller OA; Stalla GK; von Werder K
Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions.
Bernini GP; Argenio GF; Cerri F; Franchi F
J Endocrinol Invest; 1994 Nov; 17(10):799-804. PubMed ID: 7699214
[TBL] [Abstract][Full Text] [Related]
17. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
Hohnloser J; Von Werder K; Müller OA
Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
19. In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide.
Auernhammer CJ; Riepl RL; Schopohl J; Lehnert P; Müller OA; Stalla GK
Neuroendocrinology; 1994 Jul; 60(1):16-22. PubMed ID: 8090278
[TBL] [Abstract][Full Text] [Related]
20. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R; Black V; Hines GA; Fox LM; Boots LR
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]